Qures Group

Qures Group is a UK-based biotechnology company specializing in the development of antimicrobial solutions based on hypothiocyanite (OSCN-), a naturally occurring molecule in the human immune system. The company's proprietary technology, branded as Osceaun, is designed to combat a broad spectrum of pathogens, including bacteria, viruses, and fungi, with a specific focus on addressing antimicrobial resistance (AMR). Qures Group operates on a licensing model and has established a subsidiary, Ubiq Medicines, to lead its human health applications in areas such as sepsis and respiratory infections. Additionally, the company explores applications in veterinary medicine, agriculture, and environmental sterilization.